Harnessing The Power of
NK Cells to Defeat Cancer
News & Events
June 24th, 2020
Cytovia Therapeutics, Inc appoints Dr. Wei Li as Chief Scientific Officer to accelerate the development of iPSC CAR-NK Cell Therapy for Cancer
June 3rd, 2020
CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2
(COVID-19)
April 7th, 2020
Cytovia CEO Dr. Daniel Teper Featured on MSQ Webinar Series
March 24th, 2020
Hebrew University to Collaborate with Cytovia Therapeutics on Natural Killer Cell Research
March 18th, 2020
Webcast: BIO CEO & Investor Conference
February 12th, 2020